These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1360888)
21. Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. Kerr J; Leary JA; Hurst T; Shih YC; Antalis TM; Friedlander M; Crawford E; Khoo SK; Ward B; Chenevix-Trench G Oncogene; 1996 Oct; 13(8):1815-8. PubMed ID: 8895529 [TBL] [Abstract][Full Text] [Related]
22. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945 [TBL] [Abstract][Full Text] [Related]
23. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis. Koreth J; Bethwaite PB; McGee JO J Pathol; 1995 May; 176(1):11-8. PubMed ID: 7616353 [TBL] [Abstract][Full Text] [Related]
24. Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis. Poddighe PJ; Bringuier PP; Vallinga M; Schalken JA; Ramaekers FC; Hopman AH J Pathol; 1996 Jun; 179(2):169-76. PubMed ID: 8758209 [TBL] [Abstract][Full Text] [Related]
25. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Gabra H; Watson JE; Taylor KJ; Mackay J; Leonard RC; Steel CM; Porteous DJ; Smyth JF Cancer Res; 1996 Mar; 56(5):950-4. PubMed ID: 8640783 [TBL] [Abstract][Full Text] [Related]
26. Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours. Viel A; Giannini F; Tumiotto L; Sopracordevole F; Visentin MC; Boiocchi M Br J Cancer; 1992 Dec; 66(6):1030-6. PubMed ID: 1360809 [TBL] [Abstract][Full Text] [Related]
27. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers. Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342 [TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Millikin D; Meese E; Vogelstein B; Witkowski C; Trent J Cancer Res; 1991 Oct; 51(20):5449-53. PubMed ID: 1680551 [TBL] [Abstract][Full Text] [Related]
29. Allele loss on chromosome 17 in ovarian cystic teratomas. Kido M; Ito K; Shibuya M Jpn J Clin Oncol; 1994 Aug; 24(4):181-5. PubMed ID: 8072195 [TBL] [Abstract][Full Text] [Related]
30. Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas. Wright K; Wilson PJ; Kerr J; Do K; Hurst T; Khoo SK; Ward B; Chenevix-Trench G Oncogene; 1998 Sep; 17(9):1185-8. PubMed ID: 9764830 [TBL] [Abstract][Full Text] [Related]
31. Deletion mapping of the short arm of chromosome 3 in Merkel cell carcinoma. Leonard JH; Williams G; Walters MK; Nancarrow DJ; Rabbitts PH Genes Chromosomes Cancer; 1996 Feb; 15(2):102-7. PubMed ID: 8834173 [TBL] [Abstract][Full Text] [Related]
32. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178 [TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors. Wertheim I; Tangir J; Muto MG; Welch WR; Berkowitz RS; Chen WY; Mok SC Oncogene; 1996 May; 12(10):2147-53. PubMed ID: 8668340 [TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors. Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351 [TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830 [TBL] [Abstract][Full Text] [Related]
36. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666 [TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity at 11q22 correlates with low progesterone receptor content in epithelial ovarian cancer. Gabra H; Langdon SP; Watson JE; Hawkins RA; Cohen BB; Taylor L; Mackay J; Steel CM; Leonard RC; Smyth JF Clin Cancer Res; 1995 Sep; 1(9):945-53. PubMed ID: 9816065 [TBL] [Abstract][Full Text] [Related]
38. Allelic loss and replication errors at microsatellite loci on chromosome 11p in head and neck squamous carcinoma: association with aggressive biological features. El-Naggar AK; Hurr K; Huff V; Luna MA; Goepfert H; Batsakis JG Clin Cancer Res; 1996 May; 2(5):903-7. PubMed ID: 9816248 [TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy. Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540 [TBL] [Abstract][Full Text] [Related]
40. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]